1-5 of 5
Steven de Jong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition

Marta Llaurado Fernandez, E. Marielle Hijmans, Annemiek M.C. Gennissen, Nelson K.Y. Wong, Shang Li, G. Bea A. Wisman, Aleksandra Hamilton, Joshua Hoenisch, Amy Dawson, Cheng-Han Lee, Madison Bittner, Hannah Kim, Gabriel E. DiMattia, Christianne A.R. Lok, Cor Lieftink, Roderick L. Beijersbergen, Steven de Jong, Mark S. Carey, René Bernards, Katrien Berns
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (12): 1862–1874.
https://doi.org/10.1158/1535-7163.MCT-22-0004
Published: 02 December 2022
View article titled, NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
Open the PDF for NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

Ximena Rosas-Plaza, Gerda de Vries, Gert Jan Meersma, Albert J.H. Suurmeijer, Jourik A. Gietema, Marcel A.T.M. van Vugt, Steven de Jong
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (2): 590–601.
https://doi.org/10.1158/1535-7163.MCT-19-0449
Published: 06 February 2020
View article titled, Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
Open the PDF for Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment in another window
Includes: Supplementary data
Journal Articles

Abstract A86: Extracellular domain shedding influences specific tumor uptake and kinetics of EGFR PET tracer 89Zr-imgatuzumab

Martin Pool, Arjan Kol, Marjolijn N. Lub-de Hooge, Christian A. Gerdes, Steven de Jong, Elisabeth G.E. de Vries, Anton G.T. Terwisscha van Scheltinga
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A86.
https://doi.org/10.1158/1535-7163.TARG-15-A86
Published: 01 December 2015
View article titled, Abstract A86: Extracellular domain shedding influences specific tumor uptake and kinetics of EGFR PET tracer 89Zr-imgatuzumab
Journal Articles

Abstract LB-B11: Assessment of HER3 status during lapatinib treatment in HER3-positive breast cancer using 89Zr-anti-HER3 mAb

Arjan Kol, Martin Pool, Steven de Jong, Elisabeth GE de Vries, Marjolijn N. Lub-de Hooge, Anton GT Terwisscha van Scheltinga
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): LB-B11.
https://doi.org/10.1158/1535-7163.TARG-15-LB-B11
Published: 01 December 2015
View article titled, Abstract LB-B11: Assessment of HER3 status during lapatinib treatment in HER3-positive breast cancer using 89Zr-anti-HER3 mAb
Journal Articles

Abstract A8: The EurOPDX consortium: Sharing patient tumor-derived xenografts for collaborative multicentric preclinical trials.

Emilie Vinolo, Elisabetta Marangoni, Violeta Serra, Frederic Amant, Andrea Bertotti, Andrew V. Biankin, Anne-Lise Børresen-Dale, Alejandra Bruna, Eva Budinská, Annette Byrne, Carlos Caldas, David Chang, Robert Clarke, Els Hermans, Manuel Hidalgo, Steven de Jong, Jos Jonkers, Pedro López, Gunhild Mari Mælandsmo, Vlad Popovici, Sergio Roman-Roman, Joan Seoane, Livio Trusolino, Alberto Villanueva
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A8.
https://doi.org/10.1158/1535-7163.TARG-13-A8
Published: 01 November 2013
View article titled, Abstract A8: The EurOPDX consortium: Sharing patient tumor-derived xenografts for collaborative multicentric preclinical trials.